Neurocrine Bioscience buy Morgan Stanley
Start price
31.07.25
/
50%
€112.45
Target price
31.07.26
€138.22
Performance (%)
-1.47%
Price
04.08.25
€110.80
Summary
This prediction is currently active. With a performance of -1.47%, the BUY prediction for Neurocrine Bioscience by Morgan_Stanley is down slightly. This prediction currently runs until 31.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -1.47% |
iShares Core DAX® | -0.695% |
iShares Nasdaq 100 | -0.520% |
iShares Nikkei 225® | 0.870% |
iShares S&P 500 | -0.737% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $150.00 to $158.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
-1.51%
04.08.25
04.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
5.52%
04.08.25
04.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-25.14%
04.08.25
04.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25